Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Receptors, Androgen | 14 | 2021 | 1057 | 1.620 |
Why?
|
SOX9 Transcription Factor | 4 | 2013 | 146 | 0.980 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 2 | 2012 | 322 | 0.780 |
Why?
|
Prostate | 5 | 2021 | 1764 | 0.610 |
Why?
|
High Mobility Group Proteins | 2 | 2008 | 187 | 0.570 |
Why?
|
Prostatic Neoplasms | 13 | 2021 | 11039 | 0.570 |
Why?
|
Mammary Neoplasms, Animal | 2 | 2018 | 138 | 0.550 |
Why?
|
Gene Expression Regulation, Neoplastic | 10 | 2018 | 8425 | 0.490 |
Why?
|
Trans-Activators | 3 | 2013 | 2924 | 0.450 |
Why?
|
Down-Regulation | 5 | 2013 | 3001 | 0.400 |
Why?
|
Doxycycline | 1 | 2012 | 326 | 0.380 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2013 | 314 | 0.370 |
Why?
|
Androgens | 7 | 2018 | 1271 | 0.360 |
Why?
|
Transcription Factors | 6 | 2013 | 12164 | 0.320 |
Why?
|
Cell Line, Tumor | 16 | 2021 | 16665 | 0.290 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2012 | 2502 | 0.280 |
Why?
|
G1 Phase | 1 | 2006 | 415 | 0.250 |
Why?
|
Mammary Glands, Animal | 2 | 2018 | 277 | 0.240 |
Why?
|
Cell Proliferation | 4 | 2013 | 10472 | 0.220 |
Why?
|
Receptor Tyrosine Kinase-like Orphan Receptors | 1 | 2022 | 42 | 0.210 |
Why?
|
Neoplasm Transplantation | 5 | 2018 | 2085 | 0.210 |
Why?
|
Cerebellar Cortex | 1 | 2022 | 107 | 0.210 |
Why?
|
p21-Activated Kinases | 3 | 2013 | 128 | 0.200 |
Why?
|
Ischemic Postconditioning | 1 | 2020 | 25 | 0.190 |
Why?
|
Neoplasm Proteins | 1 | 2013 | 3691 | 0.180 |
Why?
|
Mice, SCID | 4 | 2018 | 2715 | 0.180 |
Why?
|
beta Catenin | 4 | 2022 | 1058 | 0.170 |
Why?
|
Radioactive Pollutants | 1 | 2018 | 12 | 0.170 |
Why?
|
Chernobyl Nuclear Accident | 1 | 2018 | 15 | 0.170 |
Why?
|
Protein Phosphatase 1 | 2 | 2017 | 137 | 0.160 |
Why?
|
Positive Transcriptional Elongation Factor B | 1 | 2017 | 43 | 0.150 |
Why?
|
Wnt Proteins | 3 | 2013 | 721 | 0.150 |
Why?
|
Cell Growth Processes | 2 | 2008 | 400 | 0.140 |
Why?
|
Epithelial-Mesenchymal Transition | 3 | 2021 | 713 | 0.140 |
Why?
|
Mice | 13 | 2022 | 81045 | 0.130 |
Why?
|
Hospitals, Urban | 1 | 2017 | 499 | 0.130 |
Why?
|
Phosphorylation | 5 | 2018 | 8436 | 0.130 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2018 | 546 | 0.120 |
Why?
|
Mice, Transgenic | 4 | 2018 | 9735 | 0.120 |
Why?
|
Genes, Reporter | 1 | 2018 | 1547 | 0.120 |
Why?
|
Mice, Inbred ICR | 2 | 2018 | 352 | 0.110 |
Why?
|
Myristic Acid | 1 | 2012 | 47 | 0.110 |
Why?
|
Dihydrotestosterone | 1 | 2013 | 188 | 0.110 |
Why?
|
Neoplasm Invasiveness | 2 | 2013 | 3612 | 0.110 |
Why?
|
Myeloproliferative Disorders | 1 | 2018 | 603 | 0.110 |
Why?
|
Hospitals, Teaching | 1 | 2017 | 1179 | 0.100 |
Why?
|
Transcription, Genetic | 3 | 2021 | 7721 | 0.100 |
Why?
|
Enzyme Induction | 1 | 2012 | 475 | 0.100 |
Why?
|
Breast Neoplasms | 4 | 2013 | 20774 | 0.100 |
Why?
|
CDC2 Protein Kinase | 2 | 2017 | 220 | 0.100 |
Why?
|
Neural Pathways | 1 | 2022 | 2971 | 0.100 |
Why?
|
Protein Kinase C-alpha | 1 | 2011 | 112 | 0.100 |
Why?
|
Operon | 1 | 2012 | 360 | 0.100 |
Why?
|
Animals | 14 | 2022 | 168561 | 0.100 |
Why?
|
Mammary Glands, Human | 1 | 2013 | 200 | 0.100 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 1 | 2013 | 437 | 0.100 |
Why?
|
RNA, Small Interfering | 3 | 2016 | 3504 | 0.100 |
Why?
|
Epithelial Cells | 4 | 2018 | 3678 | 0.100 |
Why?
|
Herpesvirus 4, Human | 1 | 2016 | 1040 | 0.100 |
Why?
|
Fibrinolytic Agents | 1 | 2020 | 2156 | 0.090 |
Why?
|
Nerve Net | 1 | 2022 | 2174 | 0.090 |
Why?
|
Tosyl Compounds | 2 | 2008 | 110 | 0.090 |
Why?
|
Tyrosine | 2 | 2012 | 1460 | 0.090 |
Why?
|
Castration | 1 | 2009 | 158 | 0.080 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2018 | 2455 | 0.080 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2013 | 628 | 0.080 |
Why?
|
Immediate-Early Proteins | 1 | 2011 | 453 | 0.080 |
Why?
|
Transgenes | 1 | 2012 | 1009 | 0.080 |
Why?
|
Male | 20 | 2022 | 349538 | 0.080 |
Why?
|
Coronary Artery Bypass | 1 | 2017 | 2281 | 0.080 |
Why?
|
Anilides | 2 | 2008 | 404 | 0.070 |
Why?
|
Neoplasm Metastasis | 2 | 2018 | 4839 | 0.070 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2016 | 2948 | 0.070 |
Why?
|
Enhancer Elements, Genetic | 1 | 2013 | 1337 | 0.070 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2016 | 2940 | 0.070 |
Why?
|
MAP Kinase Kinase 6 | 1 | 2004 | 25 | 0.060 |
Why?
|
Nerve Tissue Proteins | 1 | 2018 | 4465 | 0.060 |
Why?
|
Enzyme Activation | 2 | 2013 | 3701 | 0.060 |
Why?
|
Neoplastic Stem Cells | 1 | 2013 | 1376 | 0.060 |
Why?
|
Nitriles | 2 | 2008 | 952 | 0.060 |
Why?
|
Immunohistochemistry | 3 | 2016 | 11363 | 0.060 |
Why?
|
Signal Transduction | 7 | 2018 | 23387 | 0.060 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2013 | 1581 | 0.060 |
Why?
|
Cell Line | 3 | 2021 | 15994 | 0.060 |
Why?
|
Transfection | 3 | 2008 | 5892 | 0.060 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2013 | 3920 | 0.060 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2006 | 625 | 0.060 |
Why?
|
Neurons | 1 | 2022 | 9325 | 0.060 |
Why?
|
Humans | 25 | 2022 | 742088 | 0.060 |
Why?
|
Antineoplastic Agents | 2 | 2021 | 13655 | 0.050 |
Why?
|
Androgen Receptor Antagonists | 2 | 2017 | 113 | 0.050 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2011 | 2107 | 0.050 |
Why?
|
Cell Survival | 1 | 2011 | 5872 | 0.050 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2004 | 697 | 0.050 |
Why?
|
Autocrine Communication | 1 | 2022 | 171 | 0.050 |
Why?
|
Membrane Proteins | 1 | 2018 | 7873 | 0.050 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2022 | 713 | 0.050 |
Why?
|
HEK293 Cells | 2 | 2021 | 4200 | 0.050 |
Why?
|
Transcriptional Activation | 3 | 2017 | 1782 | 0.050 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2021 | 5163 | 0.040 |
Why?
|
Keratin-8 | 1 | 2018 | 11 | 0.040 |
Why?
|
Space Perception | 1 | 2022 | 474 | 0.040 |
Why?
|
Keratin-14 | 1 | 2018 | 57 | 0.040 |
Why?
|
Ukraine | 1 | 2018 | 111 | 0.040 |
Why?
|
Androgen Antagonists | 3 | 2018 | 1350 | 0.040 |
Why?
|
Carrier Proteins | 1 | 2011 | 5019 | 0.040 |
Why?
|
Calreticulin | 1 | 2018 | 97 | 0.040 |
Why?
|
Ligands | 2 | 2021 | 3293 | 0.040 |
Why?
|
Chromatin | 2 | 2021 | 2917 | 0.040 |
Why?
|
Neovascularization, Pathologic | 1 | 2008 | 2633 | 0.040 |
Why?
|
Receptors, Thrombopoietin | 1 | 2018 | 156 | 0.040 |
Why?
|
Cytoskeletal Proteins | 1 | 2003 | 1363 | 0.040 |
Why?
|
Coronary Artery Disease | 1 | 2017 | 6454 | 0.040 |
Why?
|
Cyclin-Dependent Kinase 9 | 1 | 2017 | 66 | 0.040 |
Why?
|
MicroRNAs | 1 | 2013 | 3731 | 0.040 |
Why?
|
Medical Oncology | 1 | 2009 | 2235 | 0.040 |
Why?
|
Cell Division | 2 | 2018 | 4564 | 0.040 |
Why?
|
Zebrafish Proteins | 1 | 2003 | 1004 | 0.040 |
Why?
|
Tissue Array Analysis | 1 | 2018 | 553 | 0.040 |
Why?
|
Transplantation, Heterologous | 2 | 2016 | 2382 | 0.040 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2006 | 2938 | 0.040 |
Why?
|
Prostate-Specific Antigen | 1 | 2006 | 2458 | 0.040 |
Why?
|
Loss of Heterozygosity | 1 | 2018 | 678 | 0.030 |
Why?
|
Receptors, Complement 3d | 1 | 2016 | 118 | 0.030 |
Why?
|
Hospital Bed Capacity | 1 | 2017 | 213 | 0.030 |
Why?
|
Apoptosis | 1 | 2012 | 9715 | 0.030 |
Why?
|
RNA Interference | 2 | 2016 | 2890 | 0.030 |
Why?
|
Amino Acid Motifs | 1 | 2018 | 936 | 0.030 |
Why?
|
Length of Stay | 2 | 2020 | 6294 | 0.030 |
Why?
|
Janus Kinase 2 | 1 | 2018 | 527 | 0.030 |
Why?
|
Viral Matrix Proteins | 1 | 2016 | 186 | 0.030 |
Why?
|
Feedback, Physiological | 1 | 2017 | 479 | 0.030 |
Why?
|
Tissue Plasminogen Activator | 1 | 2020 | 1262 | 0.030 |
Why?
|
Gene Dosage | 1 | 2018 | 1251 | 0.030 |
Why?
|
Cell Movement | 2 | 2018 | 5212 | 0.030 |
Why?
|
Blood Pressure | 1 | 2009 | 8541 | 0.030 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2018 | 1213 | 0.030 |
Why?
|
Genes, Lethal | 1 | 2013 | 242 | 0.030 |
Why?
|
Cell Respiration | 1 | 2013 | 200 | 0.030 |
Why?
|
Adenine | 1 | 2018 | 936 | 0.030 |
Why?
|
5-Methylcytosine | 1 | 2013 | 153 | 0.030 |
Why?
|
Immunoblotting | 1 | 2016 | 1683 | 0.030 |
Why?
|
Green Fluorescent Proteins | 1 | 2018 | 2088 | 0.030 |
Why?
|
Models, Biological | 1 | 2009 | 9581 | 0.030 |
Why?
|
Cytosine | 1 | 2013 | 216 | 0.030 |
Why?
|
In Situ Hybridization | 1 | 2016 | 1950 | 0.030 |
Why?
|
STAT3 Transcription Factor | 1 | 2016 | 874 | 0.030 |
Why?
|
Chromosome Aberrations | 1 | 2018 | 1811 | 0.030 |
Why?
|
Homeodomain Proteins | 1 | 2021 | 2417 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2016 | 1875 | 0.020 |
Why?
|
China | 1 | 2017 | 2246 | 0.020 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2013 | 474 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2006 | 13029 | 0.020 |
Why?
|
Propensity Score | 1 | 2017 | 1771 | 0.020 |
Why?
|
Protein Binding | 2 | 2018 | 9387 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2018 | 2011 | 0.020 |
Why?
|
Genome-Wide Association Study | 1 | 2009 | 12220 | 0.020 |
Why?
|
Piperidines | 1 | 2018 | 1602 | 0.020 |
Why?
|
Antibodies | 1 | 2018 | 2459 | 0.020 |
Why?
|
Phospholipase C delta | 1 | 2009 | 7 | 0.020 |
Why?
|
Fibroblast Growth Factor 5 | 1 | 2009 | 9 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2009 | 15494 | 0.020 |
Why?
|
Hippocampus | 1 | 2022 | 3661 | 0.020 |
Why?
|
Cytochrome P-450 CYP1A2 | 1 | 2009 | 68 | 0.020 |
Why?
|
DNA, Viral | 1 | 2016 | 2224 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2020 | 3502 | 0.020 |
Why?
|
Mutation, Missense | 1 | 2018 | 2556 | 0.020 |
Why?
|
Steroid 17-alpha-Hydroxylase | 1 | 2009 | 98 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2018 | 6382 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2016 | 2713 | 0.020 |
Why?
|
Hepatocyte Nuclear Factor 3-alpha | 1 | 2009 | 170 | 0.020 |
Why?
|
Biopsy | 1 | 2021 | 6756 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2013 | 1655 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2016 | 1670 | 0.020 |
Why?
|
Ubiquitin-Conjugating Enzymes | 1 | 2009 | 195 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2007 | 9185 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2020 | 8621 | 0.020 |
Why?
|
Pyrazoles | 1 | 2018 | 1970 | 0.020 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2009 | 284 | 0.020 |
Why?
|
Embryo, Mammalian | 1 | 2013 | 1692 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2021 | 4438 | 0.020 |
Why?
|
Female | 5 | 2020 | 379592 | 0.020 |
Why?
|
Neoplasms | 1 | 2016 | 21596 | 0.020 |
Why?
|
Quality Indicators, Health Care | 1 | 2017 | 1831 | 0.020 |
Why?
|
Systole | 1 | 2009 | 956 | 0.020 |
Why?
|
Diastole | 1 | 2009 | 791 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2018 | 5867 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 2 | 2013 | 4553 | 0.020 |
Why?
|
Phosphoserine | 1 | 2006 | 206 | 0.020 |
Why?
|
Pyrimidines | 1 | 2018 | 2933 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2013 | 2077 | 0.020 |
Why?
|
Open Reading Frames | 1 | 2009 | 810 | 0.020 |
Why?
|
Neoplasms, Hormone-Dependent | 1 | 2008 | 414 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2016 | 6891 | 0.020 |
Why?
|
GTPase-Activating Proteins | 1 | 2008 | 497 | 0.020 |
Why?
|
Odds Ratio | 1 | 2017 | 9846 | 0.020 |
Why?
|
DNA | 1 | 2018 | 7289 | 0.020 |
Why?
|
Mutation | 1 | 2009 | 29717 | 0.010 |
Why?
|
Cyproterone Acetate | 1 | 2003 | 6 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2009 | 15108 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2017 | 5310 | 0.010 |
Why?
|
Purines | 1 | 2006 | 593 | 0.010 |
Why?
|
Adult | 3 | 2018 | 213712 | 0.010 |
Why?
|
TCF Transcription Factors | 1 | 2003 | 140 | 0.010 |
Why?
|
Transcription Factor 7-Like 2 Protein | 1 | 2003 | 154 | 0.010 |
Why?
|
India | 1 | 2009 | 2187 | 0.010 |
Why?
|
Europe | 1 | 2009 | 3339 | 0.010 |
Why?
|
Aged | 3 | 2020 | 162944 | 0.010 |
Why?
|
Healthcare Disparities | 1 | 2017 | 3151 | 0.010 |
Why?
|
Survival Rate | 1 | 2016 | 12773 | 0.010 |
Why?
|
Young Adult | 2 | 2018 | 56350 | 0.010 |
Why?
|
Registries | 1 | 2017 | 8077 | 0.010 |
Why?
|
Serine | 1 | 2004 | 828 | 0.010 |
Why?
|
Middle Aged | 3 | 2020 | 213127 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 2009 | 4742 | 0.010 |
Why?
|
Prevalence | 1 | 2017 | 15194 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2016 | 19223 | 0.010 |
Why?
|
Histones | 1 | 2009 | 2597 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2016 | 11470 | 0.010 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2009 | 2906 | 0.010 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2009 | 2915 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2004 | 3847 | 0.010 |
Why?
|
Risk Assessment | 1 | 2017 | 23320 | 0.010 |
Why?
|
Time Factors | 1 | 2017 | 40054 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2003 | 6313 | 0.010 |
Why?
|
Proteins | 1 | 2009 | 6096 | 0.010 |
Why?
|
Genetic Variation | 1 | 2009 | 6540 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2009 | 9639 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2017 | 62966 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2006 | 5522 | 0.010 |
Why?
|
Risk Factors | 1 | 2017 | 72145 | 0.010 |
Why?
|
United States | 1 | 2017 | 69693 | 0.010 |
Why?
|
Adolescent | 1 | 2017 | 85649 | 0.010 |
Why?
|
Kidney | 1 | 2004 | 7167 | 0.010 |
Why?
|